Sai Life Sciences: Please refer the attachment
Sai Life Sciences (SAILIFE) filed a disclosure titled "Please refer the attachment". The company is valued at about ₹33,849 crore.
What happened
Sai Life Sciences (SAILIFE) filed a disclosure with the exchanges on 5 November 2026 at 10:54 PM titled "Please refer the attachment".
From the filing: "Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended 30 th September 2026 ."
Company snapshot
Sai Life Sciences is a mid-cap company in the Healthcare sector, with a market value of about ₹33,849 crore.
The stock last traded at ₹1,594.5, against a 52-week range of ₹783.9–₹1,697 (6.0% below the high).
Before this filing the shares had moved +1.1% over the month and +14.0% over three months. Average daily turnover over the last 20 sessions was about ₹71.58 crore.
Promoters held 34.53% at the end of Q1 FY27, down 0.08% points from the previous quarter. Foreign institutions owned 19.65% and domestic institutions 32.71%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 496 | 60.5 | 2.9 |
| Q2 FY26 | 537 | 83.8 | 4.01 |
| Q3 FY26 | 556 | 100.4 | 4.77 |
| Q4 FY26 | 602 | 104.2 | 4.93 |
| Q1 FY27 | 554 | 73.3 | 3.46 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.0% over five days; 57% of them rose the next day.
Market-wide, 10,840 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside
- JK Agri Genetics sells leasehold rights to Sai Life Sciences for ₹19.80 crore
- Sai Life Sciences Limited IPO GMP Today, Expected Listing Gain & Price Band
- Sai Life Sciences Ltd (NSE:SAILIFE) Q2 2027 Earnings Report Prev
- Sai Life Sciences - Concurrent Gainers: 8 stocks that gain for 5 days in a row
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.